Literature DB >> 12651786

Referral for genetic counselling during pregnancy: limited alertness and awareness about genetic risk factors among GPs.

Cora M Aalfs1, Ellen M A Smets, Hanneke C J M de Haes, Nico J Leschot.   

Abstract

BACKGROUND: In many countries, GPs play a key role in the referral to other medical specialists. Referral for reproductive genetic counselling during a pregnancy of women with a genetic risk factor already present before pregnancy has many disadvantages. Nevertheless, some 10-20% of the counsellees who attend a Department of Clinical Genetics for the first time are pregnant.
OBJECTIVES: We aimed to explore the role of the GP in referring women for genetic counselling during, instead of before a pregnancy.
METHOD: The GPs of 100 pregnant women who received genetic counselling were invited to participate in the study and asked to complete a questionnaire. The topics were: initiation and discussion of aspects of referral to the Department of Clinical Genetics; reasons for the referral during, instead of before a pregnancy; knowledge of genetic counselling; attitudes towards genetic counselling before a pregnancy; and attitudes towards abortion.
RESULTS: To our surprise, 29% of the GPs indicated that they had not been involved in the referral to the Department of Clinical Genetics at all. Furthermore, the referral was initiated by the patient herself in most cases (40%) and by the GPs in 31% of the cases. Of the GPs who were involved in the referral, most of them (79%) talked to their patients to different extents about what to expect from their visit to the Department of Clinical Genetics; however, potential choices after an adverse outcome at prenatal diagnosis were discussed less often (60%). The main reason for referring the patient during, instead of before her pregnancy was because the GP was unaware of a potential risk factor before pregnancy (71%) and, consequently, never had a chance to talk about a referral before (71%). Other reasons for referral during pregnancy mentioned by the GPs were reassuring the patient about the health of her unborn child (32%) and the wish of the patient to be referred during pregnancy (31%). GPs considered their knowledge of clinical genetics to be limited (mean score 5, on a scale from 0 to 10). The majority of the GPs were in favour of genetic counselling taking place before, instead of during pregnancy, and they had no great objections to abortion.
CONCLUSIONS: During pregnancy, the gatekeeper function of the GP in the referral for genetic counselling is undermined. Limited alertness and awareness among GPs about genetic risk factors in their patients played a major role in this undermined function and in the less appropriate timing of referral. Neither insufficient knowledge nor barriers to acceptance explained this lack of alertness and awareness. We advocate the implementation of routine family history taking in general practice.

Entities:  

Mesh:

Year:  2003        PMID: 12651786     DOI: 10.1093/fampra/20.2.135

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  12 in total

1.  Interactive genetic counseling role-play: a novel educational strategy for family physicians.

Authors:  Sean M Blaine; June C Carroll; Andrea L Rideout; Gord Glendon; Wendy Meschino; Cheryl Shuman; Deanna Telner; Natasha Van Iderstine; Joanne Permaul
Journal:  J Genet Couns       Date:  2008-01-30       Impact factor: 2.537

2.  Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA).

Authors:  Amanda L Laedtke; Suzanne M O'Neill; Wendy S Rubinstein; Kristen J Vogel
Journal:  J Genet Couns       Date:  2011-09-07       Impact factor: 2.537

3.  How do obstetric providers discuss referrals for prenatal genetic counseling?

Authors:  Barbara A Bernhardt; Carrie Mastromarino Haunstetter; Debra Roter; Gail Geller
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

4.  Prenatal genetic counseling in cross-cultural medicine: A framework for family physicians.

Authors:  Ashvinder K Bhogal; Fern Brunger
Journal:  Can Fam Physician       Date:  2010-10       Impact factor: 3.275

5.  Genetic education for primary care providers: improving attitudes, knowledge, and confidence.

Authors:  June C Carroll; Andrea L Rideout; Brenda J Wilson; Judith Md Allanson; Sean M Blaine; Mary Jane Esplen; Sandra A Farrell; Gail E Graham; Jennifer MacKenzie; Wendy Meschino; Fiona Miller; Preeti Prakash; Cheryl Shuman; Anne Summers; Sherry Taylor
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

6.  How do Physicians Decide to Refer Their Patients for Psychiatric Genetic Counseling? A Qualitative Study of Physicians' Practice.

Authors:  Emma Leach; Emily Morris; Hannah J White; Angela Inglis; Anna Lehman; Jehannine Austin
Journal:  J Genet Couns       Date:  2016-05-17       Impact factor: 2.537

Review 7.  A systematic review of factors that act as barriers to patient referral to genetic services.

Authors:  Türem Delikurt; Graham R Williamson; Violetta Anastasiadou; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2014-09-10       Impact factor: 4.246

8.  Effect of comprehensive oncogenetics training interventions for general practitioners, evaluated at multiple performance levels.

Authors:  Elisa J F Houwink; Arno M M Muijtjens; Sarah R van Teeffelen; Lidewij Henneman; Jan Joost Rethans; Florijn Jacobi; Liesbeth van der Jagt; Irina Stirbu; Scheltus J van Luijk; Connie T R M Stumpel; Hanne E Meijers-Heijboer; Cees van der Vleuten; Martina C Cornel; Geert Jan Dinant
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

Review 9.  Primary-care providers' perceived barriers to integration of genetics services: a systematic review of the literature.

Authors:  Natalie A Mikat-Stevens; Ingrid A Larson; Beth A Tarini
Journal:  Genet Med       Date:  2014-09-11       Impact factor: 8.822

10.  Towards a better understanding of risk selection in maternal and newborn care: A systematic scoping review.

Authors:  Bahareh Goodarzi; Annika Walker; Lianne Holten; Linda Schoonmade; Pim Teunissen; François Schellevis; Ank de Jonge
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.